会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明授权
    • Catalytic amplification of multiplexed assay signals
    • 多重测定信号的催化扩增
    • US07358052B2
    • 2008-04-15
    • US10154641
    • 2002-05-24
    • Sharat Singh
    • Sharat Singh
    • G01N33/53G01N33/533C12Q1/42
    • G01N33/561C12Q1/6823G01N2458/10C12Q2537/143C12Q2565/125
    • Methods, compositions, kits, and a system are disclosed for detecting one or more analytes in a sample. A mixture comprising the (i) sample, (ii) a first binding reagent comprising a cleavage-inducing moiety and a first binding agent specific for an analyte, and (ii) one or more electrophoretic probes each having a second binding agent is subjected to conditions under which binding of respective binding agents occurs. The interaction between the binding agents and the analyte brings the cleavage-inducing moiety within a proximity effective for cleaving a cleavable linkage tethering an electrophoretic tag to the second binding agent, thereby releasing the tag for electrophoretic separation. Separation of different tags occurs by virtue of their distinct electrophoretic mobilities. After separation, a signal amplification moiety on each tag is activated to generate a signal to indicate the presence of a particular analyte in the sample.
    • 公开了用于检测样品中一种或多种分析物的方法,组合物,试剂盒和系统。 将包含(i)样品,(ii)包含切割诱导部分的第一结合试剂和对分析物特异性的第一结合剂的混合物和(ii)每个具有第二结合剂的一个或多个电泳探针经受 发生各自结合剂结合的条件。 结合剂和分析物之间的相互作用使得切割诱导部分在接近范围内有效,用于切割将电泳标签连接到第二结合剂的可切割连接,从而释放用于电泳分离的标签。 不同标签的分离由于其不同的电泳迁移率而发生。 分离后,激活每个标签上的信号放大部分以产生信号以指示样品中特定分析物的存在。
    • 72. 发明申请
    • METHODS OF PREDICTING AND MONITORING TYROSINE KINASE INHIBITOR THERAPY
    • 预测和监测酪氨酸激酶抑制剂治疗方法
    • US20070254295A1
    • 2007-11-01
    • US11687254
    • 2007-03-16
    • Jeanne HarveyBruce NeriSharat Singh
    • Jeanne HarveyBruce NeriSharat Singh
    • G01N33/53A61P35/00C12Q1/68
    • G06F19/18C12Q1/6886C12Q2600/106C12Q2600/154G01N33/57484G01N2333/91215G01N2500/04G01N2800/52G06F19/24
    • The present invention provides methods for analyzing a combination of biomarkers to individualize tyrosine kinase inhibitor therapy in patients who have been diagnosed with cancer. In particular, the assay methods of the present invention are useful for predicting, identifying, or monitoring the response of a tumor, tumor cell, or patient to treatment with a tyrosine kinase inhibitor using an algorithm based upon biomarker profiling. The assay methods of the present invention are also useful for predicting whether a patient has a risk of developing toxicity or resistance to treatment with a tyrosine kinase inhibitor. In addition, the assay methods of the present invention are useful for monitoring tyrosine kinase inhibitor therapy in a patient receiving the drug to evaluate whether the patient will develop resistance to the drug. Furthermore, the assay methods of the present invention are useful for optimizing the dose of a tyrosine kinase inhibitor in a patient receiving the drug to achieve therapeutic efficacy and/or reduce toxic side-effects.
    • 本发明提供了用于分析已经被诊断患有癌症的患者中的酪氨酸激酶抑制剂治疗的生物标志物的组合的方法。 特别地,本发明的测定方法可用于使用基于生物标志物分析的算法预测,鉴定或监测肿瘤,肿瘤细胞或患者用酪氨酸激酶抑制剂治疗的应答​​。 本发明的测定方法也可用于预测患者是否具有产生毒性或抗酪氨酸激酶抑制剂治疗的风险。 此外,本发明的测定方法可用于监测接受药物的患者中的酪氨酸激酶抑制剂治疗,以评估患者是否会产生对药物的抗药性。 此外,本发明的测定方法可用于优化接受该药物的患者中的酪氨酸激酶抑制剂的剂量以达到治疗功效和/或减少毒副作用。
    • 73. 发明授权
    • Methods and compositions for analyzing proteins
    • 用于分析蛋白质的方法和组合物
    • US07255999B2
    • 2007-08-14
    • US10154042
    • 2002-05-21
    • Sharat SinghHossein Salimi-MoosaviSyed Hasan TahirGerald J. WallweberHrair KirakossianTracy J. MatrayVincent S. Hernandez
    • Sharat SinghHossein Salimi-MoosaviSyed Hasan TahirGerald J. WallweberHrair KirakossianTracy J. MatrayVincent S. Hernandez
    • G01N33/53G01N33/533C12Q1/42
    • G01N33/6842C07K16/00C07K2317/40G01N33/582G01N33/6803
    • Methods, compositions and kits are disclosed for determining one or more target polypeptides in a sample where the target polypeptides have undergone a post-translational modification. A mixture comprising the sample and a first reagent comprising a cleavage-inducing moiety and a first binding agent for a binding site on a target polypeptide is subjected to conditions under which binding of respective binding moieties occurs. The binding site is the result of post-translational modification activity involving the target polypeptide. The method may be employed to determine the target polypeptide itself. In another embodiment the presence and/or amount of the target polypeptide is related to the presence and/or amount and/or activity of an agent such as an enzyme involved in the post-translational modification of the target polypeptide. The interaction between the first binding agent and the binding site brings the cleavage-inducing moiety into close proximity to a cleavable moiety, which is associated with the polypeptide and is susceptible to cleavage only when in proximity to the cleavage-inducing moiety. In this way, an electrophoretic tag for each of the polypeptides may be released. Released electrophoretic tags are separated and the presence and/or amount of the target polypeptides are determined based on the corresponding electrophoretic tags.
    • 公开了用于确定样品中一种或多种靶多肽已经经历了翻译后修饰的方法,组合物和试剂盒。 包含样品和包含切割诱导部分的第一试剂和用于靶多肽上的结合位点的第一结合剂的混合物经受各自结合部分的结合发生的条件。 结合位点是涉及靶多肽的翻译后修饰活性的结果。 该方法可用于确定靶多肽本身。 在另一个实施方案中,靶多肽的存在和/或量与试剂例如涉及靶多肽的翻译后修饰的酶的存在和/或量和/或活性有关。 第一结合剂和结合位点之间的相互作用使切割诱导部分紧密接近可切割部分,其可与多肽相关,并且仅在接近切割诱导部分时易于切割。 以这种方式,可以释放每个多肽的电泳标签。 分离释放的电泳标签,并且基于相应的电泳标签确定靶多肽的存在和/或量。
    • 75. 发明授权
    • Kits employing oligonucleotide-binding e-tag probes
    • 使用寡核苷酸结合电子标签探针的试剂盒
    • US06955874B2
    • 2005-10-18
    • US09824905
    • 2001-04-02
    • Sharat SinghTracy MatrayAhmed Chenna
    • Sharat SinghTracy MatrayAhmed Chenna
    • C12N15/09C07B61/00C07H19/06C07H19/10C07H21/00C12Q1/68B65D69/00C07H21/02C07H21/04G01H27/26
    • C07H19/06C07H19/10C07H21/00C40B70/00G01N33/561Y10S435/81
    • Kits for the multiplexed detection of known, selected nucleotide target sequences are provided. Detection involves the release of identifying tags as a consequence of target recognition. The kits include sets of electrophoretic tag probes or e-tag probes, capture agent and optionally a nuclease. The e-tag probes comprise a detection region and a mobility-defining region called the mobility modifier, both linked to a target-binding moiety. In using the kits, the target-binding moiety of the e-tag probes hybridizes to complementary target sequences followed by nuclease cleavage of the e-tag probes and release of detectable e-tags or e-tag reporters. The mixture is exposed to a capture agent which binds uncleaved and/or partially cleaved e-tag probes, followed by electrophoretic separation. In a multiplexed assay, different released e-tag reporters may be separated and detected providing for target identification.
    • 提供了用于已知选择的核苷酸靶序列的多重检测的试剂盒。 检测涉及到识别标签作为目标识别的结果。 该试剂盒包括一组电泳标签探针或电子标签探针,捕获剂和任选的核酸酶。 电子标签探针包括检测区域和称为迁移率调节剂的迁移率限定区域,两者都与靶结合部分连接。 在使用试剂盒时,e-标签探针的靶结合部分与互补的靶序列杂交,随后是e-标签探针的核酸酶切割和可检测的电子标签或电子标签记录的释放。 将混合物暴露于捕获剂,其结合未切割和/或部分切割的e-标签探针,然后进行电泳分离。 在多重测定中,可以分离和检测不同的释放的电子标签记录器,以提供目标识别。
    • 78. 发明授权
    • Methods employing oligonucleotide-binding e-tag probes
    • 使用寡核苷酸结合电子标签探针的方法
    • US06686152B2
    • 2004-02-03
    • US09825247
    • 2001-04-02
    • Sharat SinghHuan Tian
    • Sharat SinghHuan Tian
    • C12P168
    • C07H19/06C07H19/10C07H21/00C40B70/00G01N33/561Y10S435/81
    • Methods for the multiplexed detection of known, selected nucleotide target sequences are provided. Detection involves the release of identifying tags as a consequence of target recognition. The methods include the use of electrophoretic tag probes or e-tag probes, comprising a detection region and a mobility-defining region called the mobility modifier, both linked to a target-binding moiety. In practicing the methods, the target-binding moiety of the e-tag probes hybridizes to complementary target sequences followed by nuclease cleavage of the e-tag probes and release of detectable e-tags or e-tag reporters. The mixture is exposed to a capture agent which binds uncleaved and/or partially cleaved e-tag probes, followed by electrophoretic separation. In a multiplexed assay, different released e-tag reporters may be separated and detected providing for target identification.
    • 提供了多种检测已知选择的核苷酸靶序列的方法。 检测涉及到识别标签作为目标识别的结果。 所述方法包括使用电泳标签探针或电子标签探针,其包含与靶结合部分连接的检测区域和称为迁移率调节剂的迁移率限定区域。 在实施该方法时,e-标签探针的靶结合部分与互补靶序列杂交,随后是e-标签探针的核酸酶切割和可检测的电子标签或电子标签记录的释放。 将混合物暴露于捕获剂,其结合未切割和/或部分切割的e-标签探针,然后进行电泳分离。 在多重测定中,可以分离和检测不同的释放的电子标签记录器,以提供目标识别。